CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.15
arrow_downward
-1.24%(-0.090) 1D
Nov 20, 4:10:07 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7.18
High
A$7.22
Low
A$7.07
Mkt. cap
360.98M
Avg. vol.
158.22K
Volume
97.17K
Dividend
0.70%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
10.70
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$7.18
High
A$7.22
Low
A$7.07
Mkt. cap
360.98M
Avg. vol.
158.22K
Volume
97.17K
Dividend
0.70%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
10.70
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
Nacionale
·
59 minutes ago
Is the stock market down for the year? Only the Nasdaq; the S&P 500 and Dow are barely up for 2026
TradingView
·
1 hour ago
Wall Street ends sharply lower on AI selloff, S&P 500, Dow in correction
The Motley Fool
·
3 hours ago
The S&P 500 Has More Than Tripled in 10 Years, Even After Its Latest Pullback. Here’s What $1,000 in VOO Could Have Become.
BigGo Finance
·
6 hours ago
Goldman Sachs: Year-End S&P 500 Rally Could Lose Half Its Punch as Fear Runs Hot
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com